Aclaris Therapeutics (ACRS)

Trade ACRS now with
3/15/2021 7:18:16 AM Aclaris Therapeutics Completes Enrollment In Phase 2a Clinical Trial Of ATI-1777
1/19/2021 7:08:59 AM Aclaris Announces Positive Preliminary Data From 12-Week Phase 2a Trial Of Oral ATI-450 For Rheumatoid Arthritis
6/17/2020 7:09:37 AM Aclaris Therapeutics Says FDA Allows IND To Study ATI-450 In Hospitalized Patients With COVID-19
1/8/2020 8:20:23 AM Aclaris Therapeutics Names Vincent Milano To Board
9/5/2019 8:34:40 AM Aclaris Therapeutics Announces Completion Of Strategic Review Of Its Business
7/3/2019 4:06:22 PM Aclaris Therapeutics Appoints Maxine Gowen To Board Of Directors
6/17/2019 6:13:43 AM Aclaris Therapeutics Announces Positive 6-Month Results From A Phase 2 Open-Label Clinical Trial Of ATI-502
12/3/2018 7:19:03 AM Aclaris Therapeutics Closes Acquisition Of Worldwide Rights To RHOFADE Cream, 1%